טוען...
An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive
1 The effects of tenidap sodium and placebo on the pharmacokinetics of a combined oral contraceptive (Microgynon 30®) were evaluated in 18 healthy premenopausal women in a double-blind, cross-over study lasting two menstrual cycles. 2 Tenidap (120 mg day(-1)) or placebo was given for 11 days, starti...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
1995
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1364937/ https://ncbi.nlm.nih.gov/pubmed/7547095 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|